Information for new patients

Saltash Health Centre
Callington Road
Saltash
Cornwall
PL12 6DL
Tel: 01752 842281

News:

Your doctor
Is the doctor you regularly see different to the doctor you are actually registered with? If so, you can easily re-register with your usual doctor - just ask the Receptionist.

Test Results
Open for enquires Monday-Friday 10-12am & 2-5pm. In order to answer your queries more quickly we have a direct number to obtain test results. This number is only for results - 01752 844922

Out of Hours
For urgent medical problems an out of hours General Practice Service is available via the out of hours service provider. Please telephone 01752 842281 and you will be directly transferred to this service.

Flu Clinics 2010

We are holding flu clinics on Saturday 9th October and Saturday 23rd October. Vaccinations will be offered to those patients over the age of 65 or patients that fall into an "at risk" group (as set by the Department of Health). Please check with the receptionist if you are unsure of your eligibility.

Text Messaging

Missed appointments increase waiting times for all our patients. To help improve our patient services, we will send you a FREE reminder via text before your appointment. Should you no longer need your appointment early cancellation will enable us to provide care to another patient. It couldn't be easier to register - simply provide your mobile phone number and a day or so before your next appointment you will receive a reminder detailing the date and time direct to your mobile phone. Sign up now! Never miss another appointment.

Announcements

01 Sep - 01 Oct
NHS Smokefree

Find out about all of the free NHS services available to support you as you go try to give up smoking.

01 Aug - 01 Oct
NHS Summer Health

Stay safe in the sun, including sunscreens, sunburn relief, heat exhaustion, eczema and moles. Summer holidays are great fun for children, but can bring risks. Find out more

01 Jul - 01 Oct
Change for Life

Would you like loads of tips and help to make changes for a healthier future? As part of Change4Life, you will receive tons of helpful information, recipes, tools, tips, and games for the kids.

Yahoo Health

Expert warns of complacency after swine flu fizzle (AP)

Robert Webster, chairman of the Department of Virology and Molecular Biology at St. Jude Children's Research Hospital in Memphis, Tenn., attends the Options for the Control of Influenza conference in Hong Kong Sunday, Sept. 5, 2010 in Hong Kong. Webster urged health authorities around the world to stay vigilant even though the recent swine flu pandemic was less deadlier than expected, warning that bird flu could spark the next global outbreak. (AP Photo/Vincent Yu)

AP - A leading virus expert urged health authorities around the world Sunday to stay vigilant even though the recent swine flu pandemic was less deadly than expected, warning that bird flu could spark the next global outbreak.

Cholera kills 41 in Central African nation of Chad (AP)

AP - Health officials in Chad say an outbreak of cholera in the Central African nation has killed at least 41 people.

Can home cooking be hazardous to your health? (AP)

AP - Could your kitchen at home pass a restaurant inspection?

Botox maker to pay $600M to resolve investigation (AP)

Food and Drug Administration (FDA) Commissioner Margaret Hamburg speaks to reporters during a news conference at the Justice Department in Washington, Wednesday, Sep. 1, 2010, regarding a major settlement with a pharmaceutical company for False Claims Act and off-label marketing violations. Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a years long federal investigation into its marketing of the top-selling, botulin-based drug. (AP Photo/Manuel Balce Ceneta)

AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

New test seen as big advance in diagnosing TB (AP)

This undated photo released by Cepheid, shows a Cepheid Xpert MTB/RIF cartridge. The cartridge is part of a test that is a major advance in diagnosing tuberculosis and can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it. (AP Photo/Cepheid) NO SALES

AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.

Journal editors question sale of diet pill Meridia (AP)

AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

Study: Diet Drug Meridia May Boost Heart Risks (Time.com)

Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

For Bonobo Males, Mom Is the Best Wingman (LiveScience.com)

LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

Clinical Trials Update: Sept. 3, 2010 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

More parents 'redshirting' kindergartners (LiveScience.com)

LiveScience.com - As schools start back into session around the country, some parents of young children face a difficult question: Send their little ones to kindergarten as soon as they become age-eligible, or hold them back in hopes that an additional year of maturity will give them an academic boost?

MedPage Today

Investigation Reveals More Woes for Rosiglitazone

(MedPage Today) -- On July 15—a day after the FDA completed two days of hearings on rosiglitazone (Avandia)—a British advisory commission on drugs concluded that the product should be withdrawn from the market, according to an investigation conducted by BMJ.

Washington Week: Insurance, State Actions Top News

WASHINGTON (MedPage Today) -- Several studies highlighting insurance issues were released this week, including one on federal programs for kids and two others focused on employer-provided medical coverage.

FDA Approves New Eye Pressure Drop Formulation

WASHINGTON (MedPage Today) -- The FDA approved a new formulation of the drug bimatoprost (Lumigan) in a 0.01% solution as a first-line treatment to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Kids on HAART Would Benefit from Revaccinations (CME/CE)

(MedPage Today) -- Children with HIV who received standard childhood immunizations before starting on highly active antiretroviral therapy (HAART) could benefit from revaccination, a review suggests.

New Guidelines Out for Pneumococcal Vaccine (CME/CE)

(MedPage Today) -- Adults with asthma and those who smoke should receive the 23-valent polysaccharide vaccine to prevent pneumococcal disease, according to new recommendations from the CDC.

OSHA Should Dictate Residents' Hours, Group Says

WASHINGTON (MedPage Today) -- The consumer group Public Citizen is urging the Occupational Safety and Health Administration (OSHA) to regulate the work hours of resident physicians.

Four Factors Increase Risk of Opioid Dependence (CME/CE)

(MedPage Today) -- A combination of four factors appears to significantly increase the risk of opioid dependence among patients taking prescription painkillers, researchers have found.

Low IgG Poses Infection Risk With Rituximab (CME/CE)

(MedPage Today) -- Certain subgroups of patients with rheumatoid arthritis, particularly those who have low levels of IgG, are at risk for severe infections when treated with rituximab, French investigators found.

ESC: Stockholm Take Home Message -- Watch the 'Not' Warfarins

STOCKHOLM (MedPage Today) -- An investigational antiplatelet -- ticagrelor (Brilinta) -- emerged as a big winner from the five-day long European Society of Cardiology congress, but the buzz here focused instead on a trio of investigational oral anticoagulants -- dabigatran, rivaroxaban, and apixaban.

Admitting Clinical Errors Not Always Best Policy

(MedPage Today) -- Wide-scale disclosure of clinical errors seems intuitively to be the ethical choice for hospitals and physicians, but researchers from the University of Washington suggest that disclosure should be decided on a case-by-case basis rather than a one-size-fits-all solution

WHO Swine Flu

Influenza - update 115

Worldwide, H1N1 2009 virus transmission remains most intense in parts of India and in parts of the temperate southern hemisphere, particularly New Zealand and more recently in Australia.

Influenza - update 114

The situation in New Zealand and India remains largely unchanged since the last update. Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Influenza - update 113

Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Director-General statement following the ninth meeting of the Emergency Committee

The Emergency Committee held its ninth meeting by teleconference on 10 August 2010.

WHO recommendations for the post-pandemic period

The world is now in the post-pandemic period. Based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus for some years to come. While the level of concern is now greatly diminished, vigilance on the part of national health authorities remains important. Such vigilance is especially critical in the immediate post-pandemic period, when the behaviour of the H1N1 (2009) virus as a seasonal virus cannot be reliably predicted.

Pandemic (H1N1) 2009 - update 112

As of 1 August 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18449 deaths.

Pandemic (H1N1) 2009 - update 111

As of 25 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18398 deaths.

Pandemic (H1N1) 2009 - update 110

As of 18 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18366 deaths.

Monitoring patterns and levels of worldwide activity

As part of regular monitoring of H1N1 pandemic influenza, the WHO is in close dialogue with public health experts in countries worldwide, specifically to determine whether H1N1 activity has returned to levels and patterns normally seen for seasonal flu.

Pandemic (H1N1) 2009 - update 109

As of 12 July, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18337deaths.

Patient Registration

Non-English Speakers

These fact sheets have been written to explain the role of UK health services, the National Health Service (NHS), to newly-arrived individuals seeking asylum. They cover issues such as the role of GPs, their function as gatekeepers to the health services, how to register and how to access emergency services.

Special care has been taken to ensure that information is given in clear language, and the content and style has been tested with user groups.

Open the leaflets in one of the following languages

English	Urdu
Albanian	Hindi
Arabic	Lithuanian
Bulgarian	Polish
Chinese (Cantonese)	Portuguese
Chinese (Mandarin)	Spanish
Russian	French
Turkish	Punjabi
Gujerati	Somali
Croatian	Bengali

Further Information

For quick medical advice online or on the telephone contact NHS Direct